Lipopolysaccharide sensitizes the therapeutic response of breast cancer to IAP antagonist is a research paper published in Frontiers in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
New York State Department of Health
Grant: C34928GG
U.S. Department of Defense
Grant: W81XWH-22-1-0049
National Institutes of Health
Grant: R01AG049994, R01AG076731
NIA NIH HHS
Grant: R01 AG076731
Breast Cancer Coalition of Rochester
MeSH Terms
Keywords